In 2023, the FDA restricted access to widely used, naturally occurring peptides. The intent was safety. The result? Patients went underground, into unregulated gray markets, and people got sick.
This Thursday, I’m appearing before the FDA’s Pharmacy Compounding Advisory Committee to argue these therapies belong in licensed physicians’ hands, not anonymous websites.
The Insulin Innovation Left Behind
https://t.co/Mq50oscZwj
TechBuzz profiles Alison Smart’s campaign to preserve Levemir, the discontinued insulin detemir that some patients uniquely need, through stories from Michela Belluta, Kirill Zenchenko, Jaime Losinski, and Dr. Maisa Feghali, who warn alternatives can be riskier.
@SecKennedy@US_FDA Insulin dependent diabetics need basal insulin Levemir and @novonordisk took it away from USA patients to move production to weight loss drugs. Novo Nordisk had created a drug shortage for an underrepresented population so they can make more $$$ from USA's metabolic crisis! 🤬
https://t.co/TsJMGvKz3s
You have to walk it past the lies and dogma, but Google Gemini knows the score on very low carb and high protein T1D management.
@realdogenews Work in conjunction with RFK, Jr. in MAHA to ferret out and squash the regulatory capture by big food, big pharma, big war, etc. and the related bureaucrats, wherever they are.
@RobertKennedyJr @TaraG438499 Let's get all the grains and sugar out of the base of the USDA food pyramid (plate, now, I guess) and the cavity rates will fall right along with obesity.
@danabrams - excellent debate on this tonight! It was obvious who was shilling for pharmaceutical companies, but you herded the cats quite well and gave everyone a chance to make their case. @novonordisk will struggle as the truth comes out. Insulin users are struggling now. 😢
@danabrams - please do a full show on the new weight loss drugs, as you teased at the end of your show tonight. Please also include the impact that those drugs are having on insulin supply (causing shortages) and in limiting @InsulinChoice.
His insulin choice should not be taken away from him. We need Levemir to stay in production until a biosimilar can become widely available. Support @insulinalliance @novonordiskus@novonordisk